Clinical Trial Update: The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether proton pump inhibitors can prevent bleeding in gastric cancer patients. The study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Gastric Cancer, Bleeding | Phase 3 | Status: TERMINATED